Premium
The involvement of platelet‐derived growth factor receptors and insulin‐like growth factor‐I receptors signaling during mineralized nodule formation by human periodontal ligament cells
Author(s) -
Nemoto Eiji,
Shimonishi Mitsuru,
Nitta Yasutaka,
Shimauchi Hidetoshi
Publication year - 2004
Publication title -
journal of periodontal research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.31
H-Index - 83
eISSN - 1600-0765
pISSN - 0022-3484
DOI - 10.1111/j.1600-0765.2004.00750.x
Subject(s) - periodontal fiber , platelet derived growth factor receptor , growth factor , growth factor receptor , platelet derived growth factor , microbiology and biotechnology , endocrinology , chemistry , medicine , insulin like growth factor , growth factor receptor inhibitor , receptor , epidermal growth factor , biology , biochemistry , dentistry
Background and objective: Periodontal ligament cells are regarded to have the capacity to differentiate into cementoblasts or osteoblasts, and are capable of forming a mineralized nodule in vitro . However, the precise mechanisms are unclear. Here we evaluated the possible involvement of growth factor receptors, such as the platelet‐derived growth factor receptor (PDGFR), insulin‐like growth factor‐I receptor (IGF‐IR), and epidermal growth factor receptor (EGFR) on periodontal ligament cells and their ligands during periodontal ligament cells differentiation in vitro . Methods: Human periodontal ligament cells were differentiated via culturing in the presence of dexamethasone, ascorbic acid, and β‐glycerophosphate for mineralized nodule formation, characterized by von Kossa staining. Expressions of receptors and their ligands were analyzed by flow cytometry/reverse transcription‐polymerase chain reaction. Results: During the differentiation, PDGFR‐α was held at a lower level compared with the control. PDGFR‐β, however, was maintained at a slightly higher level that was reversed to the control level when mineralized nodules formed. In contrast, IGF‐IR and EGFR were not substantially different from the control. The mineralized nodule formation was strongly inhibited by a PDGFR kinase blocker (AG1295 and AG1296), partially inhibited by an IGF‐IR kinase blocker (I‐Ome‐AG538 and AG1024), and not inhibited by an EGFR kinase blocker (AG99). PDGF‐A, PDGF‐C, PDGF‐D, IGF‐I, and IGF‐II, but not PDGF‐B, were expressed on the control as well as dexamethasone/ascorbic acid‐treated periodontal ligament cells during mineralized nodule formation; however, the pattern of their expressions was quite different. Conclusion: These findings suggest that a pathway of PDGFs/PDGFR and IGFs/IGF‐IR on periodontal ligament cells are involved during mineralized nodule formation, and that PDGFs and IGFs expressed by periodontal ligament cells may contribute to the formation.